Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- HCC (3)
- Cholangiocarcinoma (2)
- Liver (2)
- Apoptosis (1)
- Biliary tract cancer (1)
-
- CRISPR/Cas (1)
- CXCr4 (1)
- DNAJB1-PRKACA (1)
- EGFR (1)
- Fibrolamellar Hepatocellular Carcinoma (1)
- Hepatoblastoma (HB); Yap; TEAD2-VP16; TEAD4 (1)
- Ibrutinib (1)
- KLF2 (1)
- Kinase fusion (1)
- MTOR (1)
- MYC (1)
- Migration (1)
- Mir210 (1)
- NELFE (1)
- Nanoparticles (1)
- Proliferation (1)
- RNA Binding proteins (1)
- RNA binding proteins (1)
- Sex as biological factor (1)
- Signaling (1)
- Sorafenib (1)
- Tristetraprolin (1)
- Tumor model (1)
- Wnt/Beta catenin (1)
Articles 1 - 8 of 8
Full-Text Articles in Life Sciences
Yap Functions Via Tead Mediated Transcriptional Activation In Hepatoblastoma Pathogenesis, Junyan Tao 8598903, Pin Liu, Jie Zhang, Sucha Singh, Xin Chen, Na Zhan, Satdarshan (Paul) Singh Monga
Yap Functions Via Tead Mediated Transcriptional Activation In Hepatoblastoma Pathogenesis, Junyan Tao 8598903, Pin Liu, Jie Zhang, Sucha Singh, Xin Chen, Na Zhan, Satdarshan (Paul) Singh Monga
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
Survival Model Of Intrahepatic Cholangiocarcinoma; Sex As A Biological Variable, Mary A. Phillippi, Justin L. Mott, Cody J. Wehrkamp, Ying Xie, David Oupicky, Ashley M. Mohr, Bailey A. Stringham
Survival Model Of Intrahepatic Cholangiocarcinoma; Sex As A Biological Variable, Mary A. Phillippi, Justin L. Mott, Cody J. Wehrkamp, Ying Xie, David Oupicky, Ashley M. Mohr, Bailey A. Stringham
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
Ibrutinib In Combination With Sorafenib Synergistically Inhibits Proliferation And Survival Of Hepatocellular Carcinoma Cells By Targeting Egfr Signaling Pathway, Cho-Hao Lin, Nissar Wani, Khadija Elkholy, Kalpana Ghoshal
Ibrutinib In Combination With Sorafenib Synergistically Inhibits Proliferation And Survival Of Hepatocellular Carcinoma Cells By Targeting Egfr Signaling Pathway, Cho-Hao Lin, Nissar Wani, Khadija Elkholy, Kalpana Ghoshal
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
Convergence Of Wnt/Beta-Catenin And Mtor Signaling In Liver Physiology And Hepatocellular Carcinoma, Adeola O. Adebayo Michael, Junyan Tao, Satdarshan P. Monga
Convergence Of Wnt/Beta-Catenin And Mtor Signaling In Liver Physiology And Hepatocellular Carcinoma, Adeola O. Adebayo Michael, Junyan Tao, Satdarshan P. Monga
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
Oncogenic Nelfe Enhances Myc-Induced Hepatocellular Carcinogenesis, Hien Dang, Atsushi Takai, Marshonna Forgues, Yosawat Pomyen, Haiwei Mou, Wen Xue, Debashish Ray, Kevn Ha, Quiad Morris, Timothy Hughes, Xin Wei Wang
Oncogenic Nelfe Enhances Myc-Induced Hepatocellular Carcinogenesis, Hien Dang, Atsushi Takai, Marshonna Forgues, Yosawat Pomyen, Haiwei Mou, Wen Xue, Debashish Ray, Kevn Ha, Quiad Morris, Timothy Hughes, Xin Wei Wang
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
Hepatocyte-Specific Deletion Of Tristetraprolin Family Of Rna Binding Proteins Result In The Development Of Hepatocellular Carcinomas, Sonika Patial
Hepatocyte-Specific Deletion Of Tristetraprolin Family Of Rna Binding Proteins Result In The Development Of Hepatocellular Carcinomas, Sonika Patial
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
The Role Of Kinase Fusion Dnajb1-Prkaca In Fibrolamellar Hepatocellular Carcinoma, Yi Guo
The Role Of Kinase Fusion Dnajb1-Prkaca In Fibrolamellar Hepatocellular Carcinoma, Yi Guo
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.
Kruppel-Like Factor 2 In Cholangiocarcinoma, Cody J. Wehrkamp, Justin L. Mott
Kruppel-Like Factor 2 In Cholangiocarcinoma, Cody J. Wehrkamp, Justin L. Mott
Hepatobiliary Cancers: Pathobiology and Translational Advances
No abstract provided.